Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dorien Leenaerts"'
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 60:46-53
Introduction: Total CO2, or bicarbonate, is a parameter in clinical chemistry often applied to assess the metabolic status of a patient. This article discusses the observations and interventions during an episode of assay instability on an Abbott Arc
Autor:
Stéphane Loyau, Dirk Hendriks, Mikael Mazighi, Jean-Philippe Desilles, William Boisseau, Martine Jandrot-Perrus, Dorien Leenaerts, Joachim C. Mertens, Jean-Baptiste Michel, Anne-Marie Lambeir, Célina Ducroux, Lucas Di Meglio
Publikováno v:
Journal of thrombosis and haemostasis
Background: Carboxypeptidase U (CPU, CPB2, TAFIa) is a potent attenuator of fibrinolysis. The inhibition of CPU is thus an interesting strategy for improving thrombolysis. Objectives: The time course of CPU generation and proCPU consumption were asse
Autor:
P.P. De Deyn, Margareta Ieven, Dorien Leenaerts, Dirk Hendriks, Anne-Marie Lambeir, Joachim C. Mertens, Raf Brouns, S. Engelborghs
Publikováno v:
Journal of thrombosis and haemostasis
Essentials Little is known of procarboxypeptidase U (proCPU) in cerebrospinal fluid (CSF) of stroke patients. ProCPU levels were studied in CSF of controls and non-thrombolyzed acute ischemic stroke patients. ProCPU is elevated in CSF of stroke patie
Autor:
Dirk Hendriks, Karen Claesen, Anne-Marie Lambeir, Joachim C. Mertens, Yani Sim, Dorien Leenaerts
Publikováno v:
Journal of thrombosis and haemostasis
Essentials Hemolytic influence on the (pro)carboxypeptidase U ((pro)CPU) system is not known. In the current manuscript, this was assessed by spiking pooled normal plasma with hemolysate. CPU activity, proCPU levels, and clot lysis times showed a dos
Autor:
Jean-Baptiste Michel, Dirk Hendriks, Martine Jandrot-Perrus, Anne-Marie Lambeir, Stéphane Loyau, Dorien Leenaerts, William Boisseau, Joachim C. Mertens
Publikováno v:
Journal of thrombosis and haemostasis
Essentials AZD9684 is a potent inhibitor of carboxypeptidase U (CPU, TAFIa, CPB2). The effect of AZD9684 on fibrinolysis was investigated in four in vitro systems. The CPU system also attenuates fibrinolysis in more advanced hemostatic systems. The s
Autor:
Yani Sim, Jef Aernouts, Dirk Hendriks, Dorien Leenaerts, Anne-Marie Lambeir, Pieter Van der Veken
Publikováno v:
Thrombosis and haemostasis : international journal for vascular biology and medicine
SummaryCarboxypeptidase U (CPU, CPB2, TAFIa) is a basic carboxypeptidase that is able to attenuate fibrinolysis. The inactive precursor procarboxypeptidase U is converted to its active form by thrombin, the thrombin-thrombomodulin complex or plasmin.
Autor:
Dorien Leenaerts, Anne-Marie Lambeir, P. Van der Veken, Dirk Hendriks, J. M. Bosmans, Yani Sim
Publikováno v:
Journal of thrombosis and haemostasis
Summary Background Two decades after its discovery, carboxypeptidase U (CPU, CPB2 or TAFIa) has become a compelling drug target in thrombosis research. However, given the difficulty of measuring CPU in the blood circulation and the demanding sample c